FIRST LIGHT ACQU(FLAG) - 2025 Q2 - Quarterly Results

Exhibit 99.1 Calidi Biotherapeutics Reports Second Quarter 2025 Financial Results and Recent Operational Highlights SAN DIEGO, August 8, 2025 — (Business Wire) — Calidi Biotherapeutics Inc. (NYSE American: CLDI) ("Calidi"), a clinical-stage biotechnology company pioneering the development of targeted therapies with the potential to deliver genetic medicines to distal sites of disease, today reported its second quarter 2025 operating and financial results and reviewed recent business highlights. "We are extr ...